companydirectorylist.com  वैश्विक व्यापार निर्देशिकाएँ और कंपनी निर्देशिकाएँ
खोज व्यवसाय , उद्योग, कंपनी :


देश सूचियाँ
संयुक्त राज्य अमेरिका कंपनी निर्देशिकाएँ
कनाडा व्यापार सूचियाँ
ऑस्ट्रेलिया व्यापार निर्देशिका
फ्रांस कंपनी सूची
इटली कंपनी सूचियाँ
स्पेन कंपनी निर्देशिका
स्विटज़रलैंड व्यवसाय सूची
ऑस्ट्रिया कंपनी निर्देशिका
बेल्जियम व्यापार निर्देशिका
हांगकांग कंपनी सूचियाँ
चीन व्यापार सूचियाँ
ताइवान की कंपनी सूचियाँ
संयुक्त अरब अमीरात कंपनी निर्देशिकाएँ


उद्योग कैटलॉग
संयुक्त राज्य अमेरिका उद्योग निर्देशिकाएँ














  • IMBRUVICA® (ibrutinib) | Official Patient Website
    Find important information about IMBRUVICA® (ibrutinib) uses, dosing, support, and more on the official patient website See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
  • IMBRUVICA® Side Effects - CLL SLL | IMBRUVICA® (ibrutinib)
    The most common side effects of IMBRUVICA® in adults with B-cell malignancies (CLL SLL and WM) include low platelet count; diarrhea; tiredness; muscle, bone, and joint pain; low white blood cell count; rash; low red blood cell count (anemia); bruising; and nausea
  • How Does IMBRUVICA® (ibrutinib) Work?
    Learn how IMBRUVICA® works for chronic lymphocytic leukemia treatment and small lymphocytic lymphoma See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
  • Taking IMBRUVICA® | IMBRUVICA® (ibrutinib)
    Find IMBRUVICA® (ibrutinib) dosing information and helpful tips for adding it to your routine and keeping track of treatments See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
  • IMBRUVICA® Side Effects Dosing - WM | IMBRUVICA® (ibrutinib)
    View important information about IMBRUVICA® side effects, tips for side effects, and IMBRUVICA® dosage information for WM See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
  • CLL and SLL Treatment | IMBRUVICA® (ibrutinib)
    Learn about treating chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) with IMBRUVICA® (ibrutinib) See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
  • WM Treatment | IMBRUVICA® (ibrutinib)
    Find important information for patients about IMBRUVICA® (ibrutinib), a treatment for waldenström’s macroglobulinemia (WM) See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
  • IMBRUVICA® By Your Side | IMBRUVICA® (ibrutinib)
    Learn about IMBRUVICA® (ibrutinib) By Your Side, a patient assistance program that provides financial options and support See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website




व्यापार निर्देशिकाएँ , कंपनी निर्देशिकाएँ
व्यापार निर्देशिकाएँ , कंपनी निर्देशिकाएँ copyright ©2005-2012 
disclaimer